This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Mylan-Lamotrigine - 25 mg

Starting date:
May 25, 2013
Posting date:
June 6, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety, Quality
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-33927

Recalled products

  1. Mylan-Lamotrigine - 25 mg

Reason

Quality concerns at the manufacturing facility of the active ingredients used in the products.

Depth of distribution

Product distributed to wholesalers and pharmacies within Canada.

Affected products

A. Mylan-Lamotrigine - 25 mg

DIN, NPN, DIN-HIM
DIN 02265494
Dosage form
  • Tablets 
Strength
  • 25 mg
Lot or serial number
  • 1055103 (100 Count)
  • 1055104 (100 Count)
  • 1071320 (100 Count)
  • 1071321 (100 Count)
  • 1083053 (100 Count)
  • 1090443 (100 Count)
  • 3003517 (100 Count)
Companies
Recalling Firm
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA
Marketing Authorization Holder
Mylan Pharmaceuticals ULC
85 Advance Road
Etobicoke
M8Z 2S6
Ontario
CANADA

Date modified: